Literature DB >> 19372436

A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers.

Kevin E Thorpe1, Merrick Zwarenstein, Andrew D Oxman, Shaun Treweek, Curt D Furberg, Douglas G Altman, Sean Tunis, Eduardo Bergel, Ian Harvey, David J Magid, Kalipso Chalkidou.   

Abstract

Mesh：

Year:  2009        PMID： 19372436      PMCID： PMC2679824          DOI： 10.1503/cmaj.090523

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  11 in total

1.  Blind faith? The effects of promoting active sick leave for back pain patients: a cluster-randomized controlled trial.

Authors:  Inger B Scheel; Kåre Birger Hagen; Jeph Herrin; Cheryl Carling; Andrew D Oxman
Journal:  Spine (Phila Pa 1976)       Date:  2002-12-01       Impact factor: 3.468

2.  Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy.

Authors:  Sean R Tunis; Daniel B Stryer; Carolyn M Clancy
Journal:  JAMA       Date:  2003-09-24       Impact factor: 56.272

3.  External validity of randomised controlled trials: "to whom do the results of this trial apply?".

Authors:  Peter M Rothwell
Journal:  Lancet       Date:  2005 Jan 1-7       Impact factor: 79.321

4.  A clinical research strategy to support shared decision making.

Authors:  Sean R Tunis
Journal:  Health Aff (Millwood)       Date:  2005 Jan-Feb       Impact factor: 6.301

5.  A simple and valid tool distinguished efficacy from effectiveness studies.

Authors:  Gerald Gartlehner; Richard A Hansen; Daniel Nissman; Kathleen N Lohr; Timothy S Carey
Journal:  J Clin Epidemiol       Date:  2006-08-04       Impact factor: 6.437

6.  Explanatory and pragmatic attitudes in therapeutical trials.

Authors:  D Schwartz; J Lellouch
Journal:  J Chronic Dis       Date:  1967-08

7.  Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units.

Authors:  S Caritis; B Sibai; J Hauth; M D Lindheimer; M Klebanoff; E Thom; P VanDorsten; M Landon; R Paul; M Miodovnik; P Meis; G Thurnau
Journal:  N Engl J Med       Date:  1998-03-12       Impact factor: 91.245

8.  Randomised controlled trial of self-supervised and directly observed treatment of tuberculosis.

Authors:  M Zwarenstein; J H Schoeman; C Vundule; C J Lombard; M Tatley
Journal:  Lancet       Date:  1998-10-24       Impact factor: 79.321

9.  Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis.

Authors:  H J M Barnett; D W Taylor; R B Haynes; D L Sackett; S J Peerless; G G Ferguson; A J Fox; R N Rankin; V C Hachinski; D O Wiebers; M Eliasziw
Journal:  N Engl J Med       Date:  1991-08-15       Impact factor: 91.245

10.  CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group.

Authors: 
Journal:  Lancet       Date:  1994-03-12       Impact factor: 79.321
View more
  158 in total

Review 1.  Comparative Effectiveness Research in Pediatric Respiratory Disease: Promise and Pitfalls.

Authors:  Kathleen J Ramos; Ranjani Somayaji; David P Nichols; Christopher H Goss
Journal:  Paediatr Drugs       Date:  2018-02       Impact factor: 3.022

2.  Behavioral medicine and the health of our nation: accelerating our impact.

Authors:  Karen Emmons
Journal:  Ann Behav Med       Date:  2012-04

3.  Developing robust, sustainable, implementation systems using rigorous, rapid and relevant science.

Authors:  Russell E Glasgow; David Chambers
Journal:  Clin Transl Sci       Date:  2012-02-23       Impact factor: 4.689

4.  Multilevel research and the challenges of implementing genomic medicine.

Authors:  Muin J Khoury; Ralph J Coates; Mary L Fennell; Russell E Glasgow; Maren T Scheuner; Sheri D Schully; Marc S Williams; Steven B Clauser
Journal:  J Natl Cancer Inst Monogr       Date:  2012-05

Review 5.  State-of-the-art and future directions in multilevel interventions across the cancer control continuum.

Authors:  Kurt C Stange; Erica S Breslau; Allen J Dietrich; Russell E Glasgow
Journal:  J Natl Cancer Inst Monogr       Date:  2012-05

6.  Reaiming RE-AIM: using the model to plan, implement, and evaluate the effects of environmental change approaches to enhancing population health.

Authors:  Diane K King; Russell E Glasgow; Bonnie Leeman-Castillo
Journal:  Am J Public Health       Date:  2010-09-23       Impact factor: 9.308

Review 7.  Randomized controlled trials and neuro-oncology: should alternative designs be considered?

Authors:  Alireza Mansouri; Samuel Shin; Benjamin Cooper; Archita Srivastava; Mohit Bhandari; Douglas Kondziolka
Journal:  J Neurooncol       Date:  2015-08-22       Impact factor: 4.130

8.  The RICH LIFE Project: A cluster randomized pragmatic trial comparing the effectiveness of health system only vs. health system Plus a collaborative/stepped care intervention to reduce hypertension disparities.

Authors:  Lisa A Cooper; Jill A Marsteller; Kathryn A Carson; Katherine B Dietz; Romsai T Boonyasai; Carmen Alvarez; Chidinma A Ibe; Deidra C Crews; Hsin-Chieh Yeh; Edgar R Miller; Cheryl R Dennison-Himmelfarb; Lisa H Lubomski; Tanjala S Purnell; Felicia Hill-Briggs; Nae-Yuh Wang
Journal:  Am Heart J       Date:  2020-05-08       Impact factor: 4.749

9.  Physicians declining patient enrollment in a critical care trial: a case study in thromboprophylaxis.

Authors:  D Cook; Y Arabi; N Ferguson; D Heels-Ansdell; A Freitag; E McDonald; F Clarke; S Keenan; G Pagliarello; W Plaxton; M Herridge; T Karachi; S Vallance; J Cade; T Crozier; S Alves da Silva; R Costa Filho; N Brandao; I Watpool; T McArdle; G Hollinger; Y Mandourah; M Al-Hazmi; N Zytaruk; N K J Adhikari
Journal:  Intensive Care Med       Date:  2013-12       Impact factor: 17.440

10.  Adherence to blood pressure telemonitoring in a cluster-randomized clinical trial.

Authors:  Tessa J Kerby; Stephen E Asche; Michael V Maciosek; Patrick J O'Connor; Joann M Sperl-Hillen; Karen L Margolis
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-07-26       Impact factor: 3.738
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.